InductOs (dibotermin alfa)-Important Safety Information from Wyeth as approved by the Irish Medicines Board

Notice type: 3rd Party Publications

Date: 19/05/2008

Problem Or Issue:
Please find herewith an important safety communication from Wyeth Pharmaceuticals Limited on the association of InductOS (dibotermin alfa) with reports of infections, in patients receiving InductOS for acute open tibia fractures using a reamed intramedullary nail. InductOS 12mg Kit for implant EU/1/02/226/001.

« Back